GLP-1 receptor agonists such as semaglutide (Ozempic), tirzepatide (Mounjaro, Zepbound), and liraglutide (Victoza) are advanced medical versions of a hormone your gut produces
Although experimental studies suggest potential pancreatic harm from GLP-1 RAs, robust clinical evidence demonstrates that these drugs do not increase the incidence of pancreatitis or pancreatic cancer in diverse human populations
No SAEs were reported, and none of the AEs led to premature treatment discontinuation
Seeing Results In 90 Days Because this month is all about real hair growth solutions, we invite you to embark on your own hair growth journey with us
While weight loss is often the most visible benefit, GLP-1 medications may support other symptoms common in perimenopause: They may reduce visceral fat , which is linked with inflammation and reduced estrogenic protections in mid-life